NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

數字呼吸設備的全球市場(2021-2030):傳感器,智能吸入器,霧化器,應用,9個國家/地區的數據,競爭狀況

Global Digital Respiratory Devices Market: Focus on Sensors, Smart Inhalers and Nebulizers, Application, 9 Countries Data, and Competitive Landscape - Analysis and Forecast, 2021-2030

出版商 BIS Research Inc. 商品編碼 999056
出版日期 內容資訊 英文 191 Pages
商品交期: 最快1-2個工作天內
價格
數字呼吸設備的全球市場(2021-2030):傳感器,智能吸入器,霧化器,應用,9個國家/地區的數據,競爭狀況 Global Digital Respiratory Devices Market: Focus on Sensors, Smart Inhalers and Nebulizers, Application, 9 Countries Data, and Competitive Landscape - Analysis and Forecast, 2021-2030
出版日期: 2021年03月30日內容資訊: 英文 191 Pages
簡介

到2030年,全球數字呼吸器市場預計將增長到4.051億美元。

本報告調查了數字呼吸器的全球市場,定義並概述了市場,分析了對市場增長,業務模型,市場規模趨勢/預測,產品類型/指示/各種細分的影響因素,例如區域/主要國家/地區,競爭環境,主要公司的概況等。

第1章市場概述

第2章市場動態

  • 影響分析
  • 市場驅動力
  • 市場約束因素
  • 市場機會

第3章COVID-19的影響

第4章競爭情況

  • 主要發展/戰略
  • 市場份額分析
  • 行業吸引力

第5章工業考慮

  • 市場機會圖分析:智能吸入器/霧化器
  • 提供給利益相關者的價值
  • 智能吸入器/霧化器:預測疾病惡化的重要因素
  • 商業模式

第6章市場分析/預測:按產品類型

  • 傳感器應用
  • 智能吸入器/霧化器

第7章市場分析/預測:按指示

  • 哮喘
  • 慢性阻塞性肺疾病(COPD)

第8章市場分析/預測:按地區/主要國家/地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 澳大利亞
    • 印度
    • 其他
  • 其他地區

第9章公司簡介

  • 3M Health Care?Limited
  • Adherium Limited
  • Amiko Digital Health Limited
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Capsule Technologies, Inc.
  • Cognita Labs
  • Cohero Health
  • Findair Sp. z. o. o
  • GlaxoSmithKline plc
  • Novartis AG
  • Pneuma Respiratory, Inc.
  • Propeller Health
  • Sensirion AG
  • Teva Pharmaceuticals Industries Ltd.

第10章 調查範圍與調查方法

目錄
Product Code: BHM0717SB

“Global Digital Respiratory Devices Market to Reach $405.1 Million by 2030.”

Market Report Coverage - Digital Respiratory Devices

Market Segmentation

  • By Product (Sensors and Apps, and Smart Inhalers and Nebulizers)
  • By Indication (Asthma and Chronic Obstructive Pulmonary Disease)

Regional Segmentation

  • North America - U.S., and Canada
  • Europe - Germany, U.K., France, Rest-of-Europe
  • Asia-Pacific - China, Japan, India, Australia, and Rest-of-Asia-Pacific
  • Rest-of-the-World

Growth Drivers

  • Increasing prevalence of respiratory diseases
  • Increasing adoption of digital technology among individuals
  • Treatment satisfaction with inhaled therapy among individuals

Market Restraints

  • Issues related to the accuracy and reliability of the device
  • Availability and high cost associated with digital respiratory devices

Market Opportunities

  • Expansion into the emerging markets
  • Predicting future exacerbations

Key Companies Profiled

  • 3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp. z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.

Key Questions Answered in this Report:

  • How pharmaceutical companies are capitalizing on the opportunity for connected inhalers to improve drug sales?
  • What has been the impact of the COVID-19 pandemic on global digital respiratory devices market?
  • What are the potential recovery scenarios of the market from the COVID-19 pandemic, and how can it impact the market forecast?
  • How will the pharma industry evolve in terms of drug-based devices in the future?
  • What are the potential business models in global digital respiratory devices market?
  • What are the major market drivers, challenges, and opportunities in the global digital respiratory devices market?
  • What are the underlying structures resulting in the emerging trends within the digital respiratory devices industry?
  • What was the market value of the leading segments and sub-segments of the global digital respiratory devices market in 2021?
  • How is each segment of the global digital respiratory devices market expected to grow during the forecast period and what is the revenue anticipated to be generated by each of the segments by the end of 2030?
  • What are the influencing factors that may affect the market share of the key players?
  • What is the market share of each of the companies in the global digital respiratory devices market and what are their contributions?

Key USPs of the Report

Following are some of the key contents of the report:

Porter's five forces analysis

This section includes exhaustive information on the competitive intensity of the market which helps any firm to understand the market, the competitors entering or leaving the market, and the firm's competitive strategy to operate in the market.

Business Model Analysis

This section comprises information on the key business models deployed in the market by leading players.

Impact of COVID-19

This section of the report encompasses the following:

  • Impact on digital respiratory devices Demand and Supply
  • Future Impact (Short-, mid-, and long-term)
  • Entry Barrier and Opportunities for New Entrants

In addition, the report provides:

  • A detailed analysis and growth forecast (2021-2030) for different indications
  • Recent developments and trends in the global market landscape
  • Factors promoting and inhibiting the market growth

Expert Quote

"Lack of consumer awareness is a key barrier to market entry for new players. Digital awareness among consumers is in the process of growth. However, more awareness needs to be created for the same. The lack of an established consumer base can hamper a start-up's ability to enter the market due to low confidence on business viability and returns."

Scope of the Global Digital Respiratory Devices Market

The purpose of the study is to enable the reader to gain a holistic view of the Global Digital Respiratory Devices Market by each of the aforementioned segments.

The report constitutes an in-depth analysis of the global digital respiratory devices market, including a thorough analysis of the different end-users. The study also provides exhaustive information on competitive landscape, brand share landscape, market share of the leading players, as well as other vital information with respect to the global digital respiratory devices market. The report considers sensors and apps, and smart inhalers and nebulizers.

Key Companies in the Global Digital Respiratory Devices Market

Some of the key players contributing to the Global Digital Respiratory Devices Market include 3M Health Care Limited, Adherium Limited, Amiko Digital Health Limited, AstraZeneca, Boehringer Ingelheim International GmbH, Capsule Technologies, Cognita Labs, Cohero Health, Findair Sp. z. o. o, GlaxoSmithKline plc, Novartis AG, Pneuma Respiratory, Propeller Health, Sensiron AG, and Teva Pharmaceuticals Industries Ltd.

Table of Contents

1 Market Overview

  • 1.1 Introduction
  • 1.2 Digital Respiratory Devices Market Ecosystem
  • 1.3 Assumptions and Limitations

2 Market Dynamics

  • 2.1 Impact Analysis
  • 2.2 Market Drivers
    • 2.2.1 Increasing Prevalence of Respiratory Diseases
    • 2.2.2 Increasing Adoption of Digital Technology Among Individuals
    • 2.2.3 Treatment Satisfaction with Inhaled Therapy Among Individuals
  • 2.3 Market Restraints
    • 2.3.1 Issues Related to The Accuracy and Reliability of the Device
    • 2.3.2 Availability and High Cost Associated with Digital Respiratory Devices
  • 2.4 Market Opportunities
    • 2.4.1 Expansion into the Emerging Markets
    • 2.4.2 Predicting Future Exacerbations

3 Analysis of COVID-19 Impact on Global Digital Respiratory Devices Market

  • 3.1 Impact on Market Size
    • 3.1.1 Scenario Comparative Analysis (Pre-COVID-19, During-COVID-19, Post-COVID-19)
    • 3.1.2 Regional Impact
      • 3.1.2.1 North America
      • 3.1.2.2 Europe
      • 3.1.2.3 Asia-Pacific
  • 3.2 Impact on Digital Respiratory Devices Adoption
    • 3.2.1 Short-Term Impact (2-4 Years)
    • 3.2.2 Mid-Term Impact (5-8 Years)
    • 3.2.3 Long-Term Impact (9-12 Years)
  • 3.3 Entry Barrier and Opportunities for New Entrants

4 Competitive Landscape

  • 4.1 Key Developments and Strategies
    • 4.1.1 Agreements and Collaborations
    • 4.1.2 Regulatory and Legal Activities
    • 4.1.3 Investments, Funding, and Business Expansion
    • 4.1.4 Mergers and Acquisitions
    • 4.1.5 Awards and Recognitions
    • 4.1.6 Product Launches
  • 4.2 Market Share Analysis
  • 4.3 Industry Attractiveness
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Buyer
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry

5 Industry Insights

  • 5.1 Opportunity Map Analysis of Smart Inhalers and Nebulizers
  • 5.2 Smart Inhaler Value Propositions for Stakeholders
  • 5.3 Smart Inhalers and Nebulizers - An Important Element of System for Predicting Disease Worsening in Individuals
  • 5.4 Business Models for Digital Respiratory Devices Market

6 Global Digital Respiratory Devices Market (by Product Type)

  • 6.1 Sensors and Apps
  • 6.2 Smart Inhalers and Nebulizers

7 Global Digital Respiratory Devices Market (by Indication)

  • 7.1 Asthma
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)

8 Global Digital Respiratory Devices Market (by Region)

  • 8.1 North America
    • 8.1.1 U.S.
    • 8.1.2 Canada
  • 8.2 Europe
    • 8.2.1 Germany
    • 8.2.2 U.K.
    • 8.2.3 France
    • 8.2.4 Rest-of-Europe
  • 8.3 Asia-Pacific (APAC)
    • 8.3.1 Japan
    • 8.3.2 China
    • 8.3.3 Australia
    • 8.3.4 India
    • 8.3.5 Rest-of-Asia-Pacific (RoAPAC)
  • 8.4 Rest-of-the-World (RoW)

9 Company Profiles

  • 9.1 3M Health Care Limited
    • 9.1.1 Company Overview
    • 9.1.2 Role of 3M Health Care Limited in the Global Digital Respiratory Devices Market
    • 9.1.3 Financials
      • 9.1.3.1 Key Insights on the Financial Health of the Company
    • 9.1.4 SWOT Analysis
  • 9.2 Adherium Limited
    • 9.2.1 Company Overview
    • 9.2.2 Role of Adherium Limited in the Global Digital Respiratory Devices Market.
    • 9.2.3 Financials
      • 9.2.3.1 Key Insights on the Financial Health of the Company
    • 9.2.4 SWOT Analysis
  • 9.3 Amiko Digital Health Limited
    • 9.3.1 Company Overview
    • 9.3.2 Role of Amiko Digital Health Limited in the Global Digital Respiratory Devices Market
    • 9.3.3 SWOT Analysis
  • 9.4 AstraZeneca plc
    • 9.4.1 Company Overview
    • 9.4.2 Role of AstraZeneca plc in the Global Digital Respiratory Devices Market
    • 9.4.3 Financials
      • 9.4.3.1 Key Insights on the Financial Health of the Company
    • 9.4.4 SWOT Analysis
  • 9.5 Boehringer Ingelheim International GmbH
    • 9.5.1 Company overview
    • 9.5.2 Role of Boehringer Ingelheim International GmbH in the Global Digital Respiratory Devices Market
    • 9.5.3 Financials
      • 9.5.3.1 Key Insights on the Financial Health of the Company
    • 9.5.4 SWOT Analysis
  • 9.6 Capsule Technologies, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Role of Capsule Technologies, Inc. in the Global Digital Respiratory Devices Market.
    • 9.6.3 SWOT Analysis
  • 9.7 Cognita Labs
    • 9.7.1 Company Overview
    • 9.7.2 Role of Cognita Labs in the Global Digital Respiratory Devices Market
    • 9.7.3 SWOT Analysis
  • 9.8 Cohero Health
    • 9.8.1 Company Overview
    • 9.8.2 Role of Cohero Health in the Global Digital Respiratory Devices Market
    • 9.8.3 SWOT Analysis
  • 9.9 Findair Sp. z. o. o
    • 9.9.1 Company Overview
    • 9.9.2 Role of Findair Sp. z. o. o in the Global Digital Respiratory Devices Market
    • 9.9.3 SWOT Analysis
  • 9.1 GlaxoSmithKline plc
    • 9.10.1 Company overview
    • 9.10.2 Role of GlaxoSmithKline plc in the Global Digital Respiratory Devices Market
    • 9.10.3 Financials
      • 9.10.3.1 Key Insights on the Financial Health of the Company
    • 9.10.4 SWOT Analysis
  • 9.11 Novartis AG
    • 9.11.1 Company overview
    • 9.11.2 Role of Novartis AG in the Global Digital Respiratory Devices Market
    • 9.11.3 Financials
      • 9.11.3.1 Key Insights on the Financial Health of the Company
    • 9.11.4 SWOT Analysis
  • 9.12 Pneuma Respiratory, Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Role of Pneuma Respiratory, Inc. in the Global Digital Respiratory Devices Market
    • 9.12.3 SWOT Analysis
  • 9.13 Propeller Health
    • 9.13.1 Company Overview
    • 9.13.2 Role of Propeller Health in the Global Digital Respiratory Devices Market
    • 9.13.3 SWOT Analysis
  • 9.14 Sensirion AG
    • 9.14.1 Company overview
    • 9.14.2 Role of Sensirion AG in the Global Digital Respiratory Devices Market
    • 9.14.3 Financials
      • 9.14.3.1 Key Insights on the Financial Health of the Company
    • 9.14.4 SWOT Analysis
  • 9.15 Teva Pharmaceuticals Industries Ltd.
    • 9.15.1 Company Overview
    • 9.15.2 Role of Teva Pharmaceuticals Industries Ltd. in the Global Digital Respiratory Devices Market
    • 9.15.3 Financials
      • 9.15.3.1 Key Insights on the Financial Health of the Company
    • 9.15.4 SWOT Analysis

10 Research Scope and Methodology

  • 10.1 Product Definition
  • 10.2 Scope of the Research Study

List of Tables

  • Table 1: Research and Facilitation Framework
  • Table 2: Global Digital Respiratory Devices Market Dynamic Impact Analysis
  • Table 2.1: Impact Analysis of Global Digital Respiratory Devices Market
  • Table 2.2: Incidence of Asthma in Key Countries, 2017-2019
  • Table 2.3: Incidence of COPD in Key Countries, 2017-2019
  • Table 3.1: Global Digital Respiratory Devices Market: Barriers to Entry
  • Table 5.1: Smart Inhaler Value Propositions for Stakeholders
  • Table 5.2: Different Data Revenue Streams
  • Table 6.1: Global Digital Respiratory Devices Market: Smart Inhalers in Pipeline
  • Table 7.1: Incidence of Asthma in Key Countries, 2017-2019
  • Table 7.2: Incidence of COPD in Key Countries, 2017-2019

List of Figures

  • Figure 1: Opportunities for Clinical Benefit
  • Figure 2: Global Digital Respiratory Devices Market, 2018-2030
  • Figure 3: Global Digital Respiratory Devices Market: Dominating Segment, 2019 and 2030
  • Figure 4: Global Digital Respiratory Devices Market (by Product Type), 2019 and 2030
  • Figure 5: Global Digital Respiratory Devices Market (by Indication), 2019 and 2030
  • Figure 6: Global Digital Respiratory Devices Market (by Region), 2019 and 2030
  • Figure 7: Global Digital Respiratory Devices: Strategies Incorporated to Expand Global Reach
  • Figure 8: Go-To-Market Strategy
  • Figure 1.1: Digital Respiratory Devices Market Workflow
  • Figure 1.2: Smart Inhalers and Data Flow
  • Figure 1.3: Digital Respiratory Devices Market Ecosystem
  • Figure 3.1: Global Digital Respiratory Devices Market: Scenario Comparative Analysis
  • Figure 3.2: COVID-19 Trend (Daily Cases), December 31, 2019-December 14, 2020
  • Figure 3.3: Global Digital Respiratory Devices Market COVID-19 Impact (by Key Regions), 2019-2030
  • Figure 3.4: Potential COVID-19 Recovery Scenarios
  • Figure 3.5: Global Prevalence (Asthma and COPD) Historical and Forecast Growth Rates, 1990-2032
  • Figure 3.6: Global Digital Respiratory Diseases Market: Opportunities for New Players
  • Figure 4.1: Competitive Landscape, January 2015-March 2021
  • Figure 4.2: Share of Key Developments and Strategies, January 2015-March 2021
  • Figure 4.3: Agreements and Collaborations Share (by Company), January 2015 - March 2021
  • Figure 4.4: Regulatory and Legal Activities Share (by Company), January 2015- March 2021
  • Figure 4.5: Investments, Funding, and Business Expansions Share (by Company), January 2015-March 2021
  • Figure 4.6: Mergers and Acquisitions Share (by Company), January 2015- March 2021
  • Figure 4.7: Awards and Recognitions Share (by Company), January 2015-March 2021
  • Figure 4.8: Product Launches Share (by Companies), January 2015-March 2021
  • Figure 4.9: Global Digital Respiratory Devices Market Share Analysis, 2018 and 2019
  • Figure 4.10: Porter's Five Forces Analysis
  • Figure 4.11: Bargaining Power of Suppliers: Overall Impact, 2018-2030
  • Figure 4.12: Bargaining Power of Buyers: Overall Impact, 2018-2030
  • Figure 4.13: Threat of New Entrant: Overall Impact, 2018-2030
  • Figure 4.14: Threat of Substitute Products: Overall Impact, 2018-2030
  • Figure 4.15: Intensity of Competitive Rivalry: Overall Impact, 2018-2030
  • Figure 5.1: Global Digital Respiratory Devices Market: Opportunity Map Analysis
  • Figure 5.2: Smart Inhalers and Nebulizers - An Important Element of System for Predicting Disease Worsening in Individuals
  • Figure 6.1: Global Digital Respiratory Devices Market (by Product Type)
  • Figure 6.2: Global Digital Respiratory Devices Market Share (by Product Type), 2019 and 2030
  • Figure 6.3: Global Digital Respiratory Devices Market (Sensors and Apps), $Million, 2018-2030
  • Figure 6.4: Global Digital Respiratory Devices Market (Smart Inhalers and Nebulizers), $Million, 2018-2030
  • Figure 7.1: Global Digital Respiratory Devices Market (by Indication)
  • Figure 7.2: Global Digital Respiratory Devices Market Share (by Indication), 2019 and 2030
  • Figure 7.3: Global Digital Respiratory Devices Market (Asthma), $Million, 2018-2030
  • Figure 7.4: Global Digital Respiratory Devices Market (COPD), $Million, 2018-2030
  • Figure 8.1: Global Digital Respiratory Devices Market (by Region)
  • Figure 8.2: Global Digital Respiratory Devices Market (by Region), $Million, 2018-2030
  • Figure 8.3: North America Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.4: North America Digital Respiratory Devices Market (by Country), $Million, 2018-2030
  • Figure 8.5: U.S. Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.6: Canada Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.7: Europe Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.8: Europe Digital Respiratory Devices Market (by Country), $Million, 2018-2030
  • Figure 8.9: Germany Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.10: U.K. Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.11: France Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.12: Rest-of-Europe Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.13: Asia-Pacific Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.14: Asia-Pacific Digital Respiratory Devices Market (by Country), 2018-2030
  • Figure 8.15: Japan Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.16: China Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.17: Australia Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.18: India Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.19: Rest-of-Asia-Pacific Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 8.20: Rest-of-the-World Digital Respiratory Devices Market, $Million, 2018-2030
  • Figure 9.1: Shares of Company Profiles
  • Figure 9.2: 3M Health Care Limited: Overall Product Portfolio
  • Figure 9.3: 3M Health Care Limited: Overall Financials, 2018-2020
  • Figure 9.4: 3M Health Care Limited: Revenue (by Business Segment), 2018-2020
  • Figure 9.5: 3M Health Care Limited: Revenue (by Region), 2018-2020
  • Figure 9.6: 3M Health Care Limited: R& D Expense, 2018-2020
  • Figure 9.7: 3M Health Care Limited: SWOT Analysis
  • Figure 9.8: Adherium Limited: Overall Product Portfolio
  • Figure 9.9: Adherium Limited: Overall Financials, 2018-2020
  • Figure 9.10: Adherium Limited: R& D Expense, 2018-2020
  • Figure 9.11: Adherium Limited: SWOT Analysis
  • Figure 9.12: Amiko Digital Health Limited: Overall Product Portfolio
  • Figure 9.13: Amiko Digital Health Limited: SWOT Analysis
  • Figure 9.14: AstraZeneca plc: Overall Product Portfolio
  • Figure 9.15: AstraZeneca plc: Overall Financials, 2018-2020
  • Figure 9.16: AstraZeneca plc: Net Revenue (by Region), 2018-2020
  • Figure 9.17: AstraZeneca plc: R& D Expense, 2018-2020
  • Figure 9.18: AstraZeneca plc: SWOT Analysis
  • Figure 9.19: Boehringer Ingelheim International GmbH: Product Offerings
  • Figure 9.20: Boehringer Ingelheim International GmbH: Overall Financials, 2017-2019
  • Figure 9.21: Boehringer Ingelheim International GmbH Net Revenue (by Business Segment), 2017-2019
  • Figure 9.22: Boehringer Ingelheim International GmbH: Net Revenue (by Region), 2017-2019
  • Figure 9.23: Boehringer Ingelheim International GmbH: R& D Expense, 2017-2019
  • Figure 9.24: AstraZeneca plc: SWOT Analysis
  • Figure 9.25: Capsule Technologies, Inc.: SWOT Analysis
  • Figure 9.26: Cognita Labs: Overall Product Portfolio
  • Figure 9.27: Cohero Health: SWOT Analysis
  • Figure 9.28: Cohero Health: Overall Product Portfolio
  • Figure 9.29: Cohero Health: SWOT Analysis
  • Figure 9.30: Findair Sp. z. o. o: Overall Product Portfolio
  • Figure 9.31: Findair Sp. z. o. o: SWOT Analysis
  • Figure 9.32: GlaxoSmithKline plc: Product Offerings
  • Figure 9.33: GlaxoSmithKline plc: Overall Financials, 2018-2020
  • Figure 9.34: GlaxoSmithKline plc Net Revenue (by Business Segment), 2018-2020
  • Figure 9.35: GlaxoSmithKline plc: Net Revenue (by Region), 2018-2020
  • Figure 9.36: GlaxoSmithKline plc: R& D Expense, 2018-2020
  • Figure 9.37: GlaxoSmithKline plc: SWOT Analysis
  • Figure 9.38: Novartis AG: Product Offerings
  • Figure 9.39: Novartis AG: Overall Financials, 2018-2020
  • Figure 9.40: Novartis AG: Net Revenue (by Business Segment), 2018-2020
  • Figure 9.41: Novartis AG: Net Revenue (by Region), 2018-2020
  • Figure 9.42: Novartis AG: R&D Expense, 2018-2020
  • Figure 9.43: Novartis AG: SWOT Analysis
  • Figure 9.44: Pneuma Respiratory, Inc.: Overall Product Portfolio
  • Figure 9.45: Pneuma Respiratory, Inc.: SWOT Analysis
  • Figure 9.46: Propeller Health: Product Offerings for Digital Respiratory Devices Market
  • Figure 9.47: Propeller Health: SWOT Analysis
  • Figure 9.48: Sensirion AG: Overall Product Portfolio
  • Figure 9.49: Sensirion AG: Overall Financials, 2017-2019
  • Figure 9.50: Sensirion AG: Net Revenue (by Business Segment), 2017-2019
  • Figure 9.51: Sensirion AG: Net Revenue (by Region), 2017-2019
  • Figure 9.52: Sensirion AG: R&D Expense, 2017-2019
  • Figure 9.53: Sensirion AG: SWOT Analysis
  • Figure 9.54: Product Offerings for Global Digital Respiratory Devices Market
  • Figure 9.55: Teva Pharmaceuticals Industries Ltd.: Net Revenue (by Business Segment), 2017-2019
  • Figure 9.56: Teva Pharmaceuticals Industries Ltd.: Net Revenue (by Region), 2017-2019
  • Figure 9.57: Teva Pharmaceuticals Industries Ltd.: R& D Expense, 2017-2019
  • Figure 9.58: Teva Pharmaceuticals Industries Ltd.: SWOT Analysis
  • Figure 10.1: Global Digital Respiratory Devices Market Segmentation
  • Figure 10.2: Research Methodology
  • Figure 10.3: Primary Research
  • Figure 10.4: Secondary Research
  • Figure 10.5: Data Triangulation
  • Figure 10.6: Bottom-up Approach (Segment-wise Analysis)
  • Figure 10.7: Top-down Approach (Segment-wise Analysis)
  • Figure 10.8: Assumptions and Limitations
  • Figure 10.9: Considered Factors for Data Prediction and Modelling